1. Introduction
===============

Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) remains a major public health issue worldwide ([@vew002-B57]), with the number of people living with HIV as high as 35.3 million and 2.3 million new infections occurring annually across the world ([@vew002-B54]). However, the development of highly active antiretroviral therapy treatment since the introduction of combination antiretroviral therapy has substantially decreased the morbidity and mortality rate of HIV patients ([@vew002-B4]; [@vew002-B29]). There are more than twenty-eight approved drugs targeting six different proteins at different steps in the viral life cycle ([@vew002-B12]; [@vew002-B62]), including those that target reverse transcriptase (RT), integrase (IN), and protease ([@vew002-B1]).

Although the long-term suppression of HIV-1 replication in many patients is achieved using strict adherence to highly active antiretroviral therapy ([@vew002-B26]; [@vew002-B44]), the high mutation rate of the HIV-1 virus often leads to the emergence of drug resistance, which is one of the major setbacks that prevents the successful anti-HIV drug/vaccine therapy in all HIV patients ([@vew002-B36]; [@vew002-B44]). Even though combination anti- retroviral therapy suppresses viral replication and prevents the emergence of drug resistance better than antiretroviral monotherapies ([@vew002-B35]; [@vew002-B1]), drug-resistant strains continue to re-emerge ([@vew002-B34]; [@vew002-B12]). Thus, the need for development of more effective treatments remains a major challenge ([@vew002-B10]), including development of an effective preventive vaccine ([@vew002-B31]; [@vew002-B23]).

RT and IN proteins play central roles in the HIV-1 life cycle. The replication of HIV-1 upon successful penetration of the host cell requires the reverse transcription of viral RNA genome and the integration of newly synthesized pro-viral DNA into the host genome by RT and IN for reverse transcription of the RNA genome and integration, respectively ([@vew002-B5]). HIV-1 RT converts single-stranded RNA into double-stranded DNA in the reverse transcription complex. After completion of reverse transcription, this reverse transcription complex will be associated into a pre-integration complex (PIC), where it comprised viral DNA, HIV-1 RT, IN, Vpr, matrix, and host cellular components. Afterward, this PIC is transported into the host nucleus where viral DNA is integrated into the host genome ([@vew002-B48]). IN-mediated integration is a three-step process. In the three-end processing, HIV-1 IN removes the terminal GT dinucleotide from both ends of viral DNA, which occurs after reverse transcription in PIC in the cytoplasm. Afterward, when PIC is transported to the nucleus, HIV-1 IN catalyses strand transfer where viral DNA is integrated into the host genome. Finally, the disintegration step occurs where viral excision has taken place ([@vew002-B6]).

Studies have shown that in HIV-1 RT and IN, enzymes physically interact and inhibit each other, suggesting the existence of functional interactions between RT and IN proteins (e.g., [@vew002-B53]; [@vew002-B39]; [@vew002-B40]; [@vew002-B61]; [@vew002-B41]; [@vew002-B42]; [@vew002-B21]; [@vew002-B55]), including the stimulation of initiation mode of RT by full-length intact IN ([@vew002-B20]). IN-RT protein complex is a key part of the PIC, which is involved in several steps of retrovirus replication, notably in reverse transcription, nuclear import, chromatin targeting and integration ([@vew002-B48]; [@vew002-B30]; [@vew002-B47]). The mechanism of protein--protein interactions of the IN--RT protein complex within PIC is not well understood. This is mainly due to the transient nature of this protein--protein complex, the dynamics of composition, and the intrinsic flexibility of its components such as IN ([@vew002-B38]; [@vew002-B22]; [@vew002-B30]; [@vew002-B47]). Structural analysis is further complicated because to date no full-length crystal structure has been published ([@vew002-B37]; [@vew002-B27]). Recently, the crystal structure of a full-length IN of prototype foamy virus (PFV) bound to viral DNA has been described. This PFV IN structure is arguably useful for the study of such protein--protein interactions, although the reliability of such analysis is unclear given the relatively low resolution of crystal structures and low sequence similarity between HIV-1 IN and PFV IN ([@vew002-B37]).

In this study, we therefore use a coevolutionary analysis as an alternative approach to identify potentially interacting regions. Because functional and physical interactions are typically reflected in coevolutionary signals in gene sequences ([@vew002-B7]; [@vew002-B9]), evolutionary rate covariation is expected to be elevated between interacting proteins ([@vew002-B9]). Here, we use a modified evolutionary rate covariation method to identify potential interacting/coevolving regions ('interacting hot-spots') between RT and IN proteins. This is the first study to use overlapping epitope regions to narrow down the list of residues involved in interaction interface(s) between two proteins. Our results show that experimentally identified interacting regions between IN and RT closely correspond to computationally identified coevolving regions.

2. Methods
==========

2.1 HIV-1 genomic sequences and sequence alignment
--------------------------------------------------

All available HIV-1 Pol protein coding DNA sequences were retrieved from the Los Alamos HIV database in July 2014 (4,407 sequences, one sequence per patient) (see [Supplementary Table S1](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1)). The nucleotide sequence alignments of IN and RT sequences were aligned according to respective amino acid alignment and were extracted using the Gene Cutter program in Los Alamos HIV Database (Gene Cutter Tool - HIV LANL Database). Ambiguously aligned regions were removed with 90 per cent coverage cut-off (i.e., only sites shared by at least 90 per cent of sequences were included in the further study) using MEGA6 ([@vew002-B52]).

2.2 IN-RT epitope clusters/non-epitope segments
-----------------------------------------------

The list of antibody (Ab), T-Helper, and best-defined cytotoxic T-lymphocytes (CTLs) epitopes was obtained for HIV-1 RT and IN regions from the HIV Immunology database (<http://www.hiv.lanl.gov/content/immunology/tables/optimal_ctl_summary.html>) ([Supplementary Table S2](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1)). The best-defined HIV CTL/CD8 + epitopes in the HXB2 reference genome are identified on the basis of the classification as described here ([@vew002-B33]). The epitopes were mapped onto the RT and IN genes ([Table 1](#vew002-T1){ref-type="table"}). Because of the frequent observation of the tendency of HIV-specific CTL epitopes to cluster in immuno-dominant regions of proteins ([@vew002-B18]), the epitopes were grouped. A cluster of epitopes that are overlapping (that includes Ab and/or T-Helper and/or best-defined CTL epitopes) is defined as one epitope cluster. The protein fragments between two epitope clusters are grouped as non-epitope segments. Because overlapping epitope peptides could promote the development of a stronger immune response than one that could be elicited using single isolated epitopes ([@vew002-B60]), our approach allows us to focus on regions that can be expected to be important to the immune response. To avoid stochastic errors associated with a small fragment size, segments shorter than six amino acids were excluded from the analyses. Table 1.Epitope clusters and non-epitope segments in HIV-1 RT and HIV-1 IN used in the study (residue coordinates are given per HXB2 amino acid coordinates).HIV-1 INHIV-1 RTEpitope cluster/non-epitope segment[^a^](#vew002-TF1){ref-type="table-fn"}Start positionEnd positionFragment size (in aa)Epitope cluster/non-epitope segment[^a^](#vew002-TF1){ref-type="table-fn"}Start positionEnd positionFragment size (in aa)IN-EP1188RT-EP111313IN-NE19157RT-EP218269IN-EP2164328RT-NE127326IN-NE2446522RT-EP3335321IN-EP3669328RT-NE2547219IN-EP49612126RT-EP4738210IN-EP512313210RT-NE3839210IN-EP61351439RT-EP59311523IN-NE314416421RT-EP611813518IN-EP716523470RT-EP713718751IN-NE42352417RT-NE41881947IN-EP824227130RT-EP819521016IN-NE527228817RT-NE521124333RT-EP924431875RT-NE631933214RT-EP1033335018RT-EP1135436613RT-NE73673748RT-EP1237540127RT-NE84024109RT-EP1341145747RT-NE945849437RT-EP1449550511RT-NE1050651914RT-EP1552054425RT-NE115455528RT-EP165535608[^1]

2.3 Random subset sampling and estimation of evolutionary rate of epitope clusters/non-epitope segments
-------------------------------------------------------------------------------------------------------

For amino acid sequences corresponding to each of the epitope clusters (Eight IN and sixteen RT epitope clusters, respectively) and non-epitope segments (five IN and eleven RT non-epitope segments, respectively), the branch lengths were estimated on the tree topology, which was generated for the full-length Pol gene by using the maximum-likelihood method with the Dayhoff substitution model, taking into account rate heterogeneity and proportions of invariant sites (Dayhoff + G + I, five class parameters for gamma distribution). We estimated the underlying tree topology for each sample for full-length nucleotide sequences of the Pol gene by using the maximum-likelihood method with the Jukes--Cantor model, taking into account rate heterogeneity and properties of invariant sites (JC + G + I, five class parameters for gamma distribution). All analyses were performed with the Computing Core MEGA version six (MEGA-CC six) as automated and iterative data analysis ([@vew002-B28]).

Rather than examining the entire dataset, a resampling technique allows the removal of sequence bias towards specific HIV-1 subtypes in the global sequence data set ([@vew002-B59]). For example, the majority of the sequences available in the database belong to subtype B (∼39%). Performing resampling is critical for reducing sampling bias when studying coevolutionary relationships between genomic regions. Therefore, the analysis was performed on 1,000 samples of 500 sequences, which were drawn from a complete set of 4,407 sequences using the simple random sampling method in R program (R Development Core Team) for all the partitioned epitope clusters and non-epitope segments. Although the treatment status was unavailable for many sequences (it was not annotated explicitly as either drug treated or drug naïve), we used the Surveillance Drug Resistance Mutation Worksheet 2014 at HIV Drug Resistance Database (<http://hivdb.stanford.edu/pages/surveillance.html>) to determine whether an individual sequence harboured drug resistance mutation. On average, about 10 per cent of sequences in each sample carried one or more resistance mutations (mean of fifty-five sequences, with the interquartile range from 50 to 59 sequences). This indicates that potential influence of resistance mutations can be expected to be approximately the same (if any) across all samples.

2.4 Estimation of evolutionary rate covariation
-----------------------------------------------

The resulting branch lengths were used to calculate the Pearson correlation coefficient (*r*) between all possible pairs of interacting epitope clusters and non-epitope segments to identify potential interacting regions. In other words, we expected branch lengths to approximate similarities in substitution patterns due to correlated changes (if any exist due to interactions) (e.g., [@vew002-B32]). The Pearson *r* values were calculated between each epitope region in IN against all epitope regions in RT for each sequence sample to determine the extent of such similarities. The combined correlation coefficient for each epitope pair across all samples was then calculated using the Pearson correlation coefficient scores, which were statistically significant at the 0.01 significance level. Because the correlation coefficients are not additive, combined correlation scores are computed on Fisher Z-transformed Pearson correlation (*r*) values ([@vew002-B15]). All statistical analyses were performed in R 3.2.0 and SAS 9.3 (SAS Institute, Cary, NC). The combined correlation coefficients were calculated only for peptide pairs that had significant correlation in at least 2/3rd of the total samples (i.e., 750 samples out of 1,000). It should be noted that alternative non-parametric approaches have been developed to detect coevolution between sites; for example, the approach based on mutual information, although its power depends on the extent of sequence conservation and structural constraints, among other limitations (e.g.,[@vew002-B14]; [@vew002-B43]). In this study, a parametric approach was chosen because of its greater sensitivity in detecting weak signals of coevolution ([@vew002-B8]).

2.5 Phylogenetically independent sister pairs
---------------------------------------------

To remove the potential influence of a shared phylogenetic history (e.g., [@vew002-B50]) on detected interactions, we repeated the analysis using phylogenetically independent comparisons of pairs of sequences ([@vew002-B13]; [@vew002-B45]). One hundred tree topologies generated for the full-length Pol gene were used to select sister pairs of sequences that had at least 50 per cent bootstrap support for the respective internal branches. Corresponding branch length values for these sister pairs (that are phylogenetically and statistically independent) were used to calculate the Pearson correlation coefficients (*r*) between all possible pairs of interacting epitope clusters and non-epitope segments. The combined correlation coefficient for each epitope pair was then calculated using the Pearson correlation coefficient scores which were statistically significant at the 0.01 significance level.

2.6 Branch length randomization
-------------------------------

To evaluate whether detected strong correlations can be attributed to background coevolution noise and/or differences in segment sizes, we used a randomization approach, with randomly permutated branch length values, to evaluate the extent of such background noise due to shared phylogenetic history and stochastic noises. For each pair of IN-RT regions, corresponding branch lengths of IN were randomly permuted 1,000 times, and correlation coefficients were computed. The combined correlation coefficient for each epitope pair was then calculated using the mean values of correlation scores, which were significant at the 0.01 level.

2.7 Sliding window analysis
---------------------------

Since some of the top coevolving regions were fairly large in size (up to seventy-five residues), we performed a sliding window analysis, using thirty amino acid long peptides with a step size of fifteen residues, which allowed us to further narrow down the range of residues that show a coevolutionary signal. There were thirty-seven and nineteen sliding windows examined in RT and IN, respectively (some sliding windows spanned several epitope or non-epitope regions). Similar to previous steps, 1,000 tree topologies generated for the full-length Pol gene were used to estimate corresponding branch length values to calculate the Pearson correlation coefficients (*r*) between all possible pairs of sliding windows. The combined correlation coefficient for each sliding window pair was then calculated using *r* scores statistically significant at the 0.01 significance level, and the top coevolving sliding window pairs were identified as those with the combined correlation coefficient values at or above 0.5.

3. Results and discussion
=========================

To identify potential interacting regions between HIV-1 IN and RT, we estimated the degree of coevolution of epitope and non-epitope regions between two proteins by calculating combined correlation coefficients of evolutionary rates of all possible region pairs. Although phylogenetic tree-based coevolution analysis has been primarily used with whole protein sequences to identify interacting proteins, phylogenetic trees derived from protein domains have also been used to identify interacting domains, under the assumption that interacting domains show stronger coevolution signals than non-interacting domains in the same protein ([@vew002-B24]; [@vew002-B25]; [@vew002-B11]; [@vew002-B9]). Here, we analysed coevolving regions between two proteins, where a region is defined as a cluster of overlapping epitopes ([Table 1](#vew002-T1){ref-type="table"}, [Fig. 1](#vew002-F1){ref-type="fig"}) located next to each other. Figure 1.The distribution of the top coevolving region pairs in major domains of HIV-1 IN and RT proteins. Dotted lines represent potential interactions among thirty-seven region pairs that have the combined correlation coefficient of at least 0.5 or higher.

3.1 Identification of coevolved sites between HIV-1 RT and IN
-------------------------------------------------------------

The combined correlation coefficient scores for all the IN-RT epitope/non-epitope cluster pairs are listed in [Supplementary Table S3](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1). The combined correlation coefficients ranged from 0.161 to 0.736 (*P* = 0.01) with a median value of 0.390 and an upper quartile at 0.457 ([Supplementary Fig. S1](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1)). Here, we primarily focused on the top 15 per cent of interactions that had combined correlation coefficient of at least 0.5 ([Table 2](#vew002-T2){ref-type="table"}). We expect that these interacting regions are more likely to experience direct and/or prolonged (as opposed to transient) interactions than the regions that have correlation values below 0.5. The latter category can be expected to experience more transient and/or indirect interactions, resulting in lower correlation coefficients. However, it is possible that our stringent cut-off of 0.5 for the combined correlation coefficients may have missed some important interactions. For example, when interferences from other proteins/substances act on the IN-RT protein complex, this could be interpreted as weak coevolution signal because external interferences are not weighted. Further, some interactions may be occurring as a result of dynamic conformational changes where both direct and indirect interactions play a role at the same sites (e.g., [@vew002-B51]; [@vew002-B47]), thereby the coevolutionary signal is unable to distinguish between different types of interactions. Table 2.Top coevolving IN-RT epitope/non-epitope segment pairs, with corresponding structural domains of the two proteins and references to experimental studies of interactions.RT epitope clusters/non-epitope segmentRelevant RT domainIN Epitope clusters/non-epitope segmentsRelevant IN domainCombined correlation coefficientLower CI at 95% confidence levelUpper CI at 95% confidence levelSample size[^a^](#vew002-TF2){ref-type="table-fn"}Identified by analysis of phylogenetically independent sister pairs[^b^](#vew002-TF3){ref-type="table-fn"}If top half of sliding windows in RT[^c^](#vew002-TF4){ref-type="table-fn"}If top half of sliding windows in IN[^c^](#vew002-TF4){ref-type="table-fn"}Experimental evidence (if available)RT-EP1Finger-PalmIN-NE5CTD0.6220.2240.843997RT-EP1Finger-PalmIN-EP2NTD0.4990.2930.660999++RT-EP11ConnectionIN-NE5CTD0.5050.1530.743950++([@vew002-B40]; [@vew002-B61])RT-EP12ConnectionIN-NE5CTD0.5850.0660.855965+([@vew002-B40]; [@vew002-B61])RT-EP12ConnectionIN-EP2NTD0.5290.1450.774941Yes++RT-EP13Connection and RNaseHIN-EP2NTD0.5310.2640.722956Yes++([@vew002-B40]; [@vew002-B61])RT-EP15RNaseHIN-EP2NTD0.5320.3730.6611,000Yes+RT-EP15RNaseHIN-NE5CTD0.5220.2360.725999++RT-EP15RNaseHIN-EP4CCD0.5030.3220.6481,000Yes++RT-EP15RNaseHIN-EP7CCD and CTD0.4950.2950.6531,000Yes+([@vew002-B42])RT-EP15RNaseHIN-NE2NTD and CCD0.4950.3280.6321,000++([@vew002-B41])RT-EP16RNaseHIN-NE5CTD0.6010.1310.851996++RT-EP16RNaseHIN-EP2NTD0.5440.3090.7161,000++RT-EP2Finger-PalmIN-NE5CTD0.5070.0590.785801++RT-EP7Finger-PalmIN-EP7CCD and CTD0.4980.2090.707994Yes++([@vew002-B40]; [@vew002-B61]; ([@vew002-B41])RT-EP8Finger-PalmIN-NE5CTD0.6580.1350.894997+([@vew002-B40]; [@vew002-B61])RT-EP8Finger-PalmIN-EP2NTD0.5550.2730.749994+RT-EP9ThumbIN-EP2NTD0.5980.4660.7051,000Yes+([@vew002-B40])RT-EP9ThumbIN-EP7CCD and CTD0.5760.3770.7241,000Yes++RT-EP9ThumbIN-EP4CCD0.5520.4000.6751,000Yes++RT-EP9ThumbIN-EP8CTD0.5420.3350.7001,000Yes+RT-EP9ThumbIN-NE5CTD0.5300.2570.725998++RT-EP9ThumbIN-EP3CCD0.5290.3940.6421,000Yes++RT-EP9ThumbIN-NE2NTD and CCD0.5260.3890.6401,000Yes+RT-NE10RNaseHIN-NE5CTD0.7080.0390.939991++RT-NE10RNaseHIN-EP6CCD0.5270.0650.803760++([@vew002-B42])RT-NE4Finger-PalmIN-NE5CTD0.5180.0260.808992++([@vew002-B40]; [@vew002-B61])RT-NE6Thumb and ConnectionIN-NE5CTD0.7360.2830.921998+([@vew002-B40])RT-NE6Thumb and ConnectionIN-EP6CCD0.5400.1320.792781++RT-NE6Thumb and ConnectionIN-EP2NTD0.5200.2420.719999++RT-NE9RNaseHIN-NE5CTD0.6040.2810.804998++[@vew002-B40]RT-NE9RNaseHIN-EP2NTD0.5850.4280.7081,000Yes++RT-NE9RNaseHIN-EP4CCD0.5650.3580.7181,000Yes++RT-NE9RNaseHIN-EP7CCD and CTD0.5450.3380.7021,000Yes+RT-NE9RNaseHIN-EP3CCD0.5410.3780.6711,000Yes++RT-NE9RNaseHIN-EP8CTD0.5080.2550.696998Yes+RT-NE9RNaseHIN-NE2NTD and CCD0.4970.3180.6421,000Yes++[^2][^3][^4][^5]

We identified 37 out of 244 epitope/non-epitope cluster pairs as the most likely regions to interact ([Fig. 1](#vew002-F1){ref-type="fig"}, [Table 2](#vew002-T2){ref-type="table"}). As listed in [Table 2](#vew002-T2){ref-type="table"}, while interactions are distributed across all the domains of RT and IN, the majority of likely interactions is observed between the regions in the C-terminal end of the Finger-Palm domain, as well as in the Thumb, Connection, and RNaseH domains in RT protein and the regions in the N-terminal and catalytic core domains (NTD and CCD, respectively) and the latter end of C-terminal domain (CTD) in IN protein (see [Fig. 1](#vew002-F1){ref-type="fig"} for details). Notably, out of thirty-seven IN-RT cluster pairs listed in [Table 2](#vew002-T2){ref-type="table"}, twenty-eight pairs have some corroborating evidence from experimental studies of IN-RT interactions, which we will discuss below.

3.2 Distribution of coevolving region pairs reveals most frequent likely interacting domains between HIV-1 RT and IN
--------------------------------------------------------------------------------------------------------------------

It is observed that the majority of likely coevolving region pairs (i.e., those with combined correlation coefficients at or above cut-off of 0.5) is located in the Finger-Palm domain and CTDs of RT and IN, respectively ([Table 2](#vew002-T2){ref-type="table"}, also [Supplementary Fig. S2](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1)). Also, there is a significant number of coevolving pairs between the Connection domain of RT that appear to interact with regions within the CCD of IN. Likewise, identified coevolving pairs indicated interactions between regions in the Finger-Palm and the Connection domains of RT and the regions in the NTD of IN, as well as regions in the Finger-Palm domain and CTD of RT and IN, respectively ([Fig. 1](#vew002-F1){ref-type="fig"}). Because the majority of the coevolving pairs identified above have combined correlation coefficients of 0.5 or higher, we expect that these domains are likely involved in direct (and/or prolonged) interactions. We should note that a substantial number of coevolving pairs with somewhat weak correlations is also located within the Finger-Palm domain and CCD of RT and IN, respectively (in other words, the number of coevolving pairs in the Finger-Palm and CCD are much higher at the threshold value of 0.4 relative to 0.5) ([Supplementary Fig. S2](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1) and [Supplementary Fig. S3](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1)). This could be attributed to the fact that these two domains play an important role in functional interaction between IN and RT, with some segments likely involved in direct interactions (i.e., those with higher combined correlation coefficients), while others (i.e., those with lower combined correlation coefficients) may be playing a supporting role and/or be interacting through one or more intermediates.

3.3 Comparison of identified coevolved epitope/non-epitope regions that corresponds to experimentally known interacting regions between HIV-1 RT and IN
-------------------------------------------------------------------------------------------------------------------------------------------------------

The experimental studies so far have shown that the C- terminal and Catalytic Core domains of IN, but not the N-terminal zinc-binding domain, were able to bind to RT ([@vew002-B20]; [@vew002-B40]; [@vew002-B42]; [@vew002-B56]), although the specific details of binding and interaction interfaces remain unknown. For example, [@vew002-B20] reported that the carboxy-terminal domain of IN alone could interact with the Finger-Palm domain and the carboxy-terminal half of the Connection subdomain of RT (residues 1--242 and 387--422 of HXB2 IN, respectively) ([@vew002-B20]). However, in the same study, it was suggested that other regions of IN may also be required for interaction with RT either directly or indirectly ([@vew002-B20]). Furthermore, [@vew002-B40] showed that a twenty amino acid-long peptide (residues 166--185, HXB2R p51) derived from the DNA polymerase active site of HIV-1 RT, which is located in the Palm sub domain, interacts with the CCD of IN and inhibits its disintegration activity ([@vew002-B40]). Several other non-inhibitory twenty amino acid-long RT-derived peptides that directly interact with full-length IN were also reported ([@vew002-B40]). The same group also described a twenty amino-acid-long peptide (residues 46--65, HXB2R p31), derived mostly from the IN-CTD that binds to RT and inhibits DNA polymerase activity and several other non-inhibitory binding peptides ([Table 2](#vew002-T2){ref-type="table"} lists specific studies available for individual segments) ([@vew002-B42]). However, the major limitation of these studies is that peptides rather than whole protein complexes were used, leaving the possibility that folded structures differ between the studied peptides and intact protein complexes *in vivo.*

The results of coevolutionary analysis showed that coevolving region pairs were not limited to the CCD and CTD but instead were distributed over the three domains of IN. This suggests that some protein regions in the NTD of IN can also interact with RT, for example, to increase the affinity of binding and/or efficiency of inhibition. Alternatively, these regions might be involved with structural stability of the IN-RT protein complex and might not be binding directly. It should be noted that coevolution analysis can provide a signal of co-functionality, either due to a direct physical binding or due to an indirect functional relationship without an explicit way to distinguish between these two types of interactions ([@vew002-B2]; [@vew002-B58]).

Approximately 75 per cent of our identified coevolving region pairs correspond to experimentally shown interacting regions of RT and IN (twenty-eight out of thirty-seven). [Table 2](#vew002-T2){ref-type="table"} lists both computationally predicted region pairs as well as any experimental evidence in support of such interactions. For example, it was shown that the most active peptide, which inhibited all IN activities (i.e., three-end processing, strand transfer, and disintegration), came from a DNA-polymerase active-site (amino acid 166--185) ([@vew002-B41]), which has been identified in our findings as well. Further, the surface loop (residues 141--148 of RT) that is disordered has been shown to be important for substrate binding and catalysis ([@vew002-B41]), in agreement with our identification of the positions 135--143 as one of the coevolving regions. On the other hand, it is possible that interactions between individual residues may have been missed because of the limitations of the coevolutionary approach, such as the interactions between Gly-149 of IN and Ile-178 of RT that were shown to interact with each other through molecular docking analysis ([@vew002-B41]).

Since the size of protein segments analysed here varied from 7 to 70 and 6 to 75 residues in IN and RT, respectively (with median sizes of twenty one and sixteen residues, respectively), our results allow us to further narrow down the size and location of peptides that are potentially interacting in the IN-RT protein complex ([Fig. 1](#vew002-F1){ref-type="fig"}, [Supplementary Fig. S4](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1)). Our results suggest that two domains of IN, including several regions in the NTD and the latter end of the C-terminal, interact with the full-length RT protein. The results also reveal strong coevolutionary signals implying existence of interactions between the Catalytic Core domain of IN and several domains of RT, including the C-terminal end of the Finger-Palm domain, as well as with the Thumb, Connection, and RNaseH domains.

By examining the number of potential interactions for each region, several segments can be identified as the top candidates due to their large number of likely interactions ([Table 2](#vew002-T2){ref-type="table"}). Specifically, within IN, IN-EP2 and IN-NE5 regions, which are located within N- and C-terminals, respectively, were found to exhibit strong correlation coefficients with ten and twelve RT regions. Likewise, within RT, RT-EP9, RT-NE9, and RT-EP15 regions, all mapped within the RNaseH domain had strong correlation coefficients with seven, seven, and five IN regions, respectively. Identification of such broadly interacting regions can help to focus future experimental studies by allowing the further narrowing down of the list of the most likely interacting positions to only about 16 per cent and 25 per cent of total positions in IN and RT, respectively (45 out of 283, and 137 out of 550 amino acid positions). Furthermore, our results may also provide a basis for excluding specific positions from consideration in experimental studies. Specifically, in RT over 35 per cent and in IN over 15 per cent of positions (194 out of 550 and 43 out of 283 positions, respectively) can be excluded as likely not interacting ones.

One of the concerns often raised in coevolutionary studies is whether an underlying phylogenetic history influences detected relationships (e.g., [@vew002-B50]). Thus, to remove the potential influence of a shared phylogenetic history, we repeated our analysis using phylogenetically independent comparisons of pairs of sequences ([@vew002-B13]); in other words, sister pairs. Combined correlation coefficients for each epitope pair were computed using only the identified sister pairs (see Section 2 for details), and the top 15 per cent (thirty-seven) scoring region pairs were examined as the most likely interacting and coevolving candidates (See [Supplementary Table S4](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1)). Notably, about half of the identified coevolving region pairs were the same as those identified in our initial analysis (eighteen out of thirty-seven region pairs; see [Table 2](#vew002-T2){ref-type="table"} for details). Further, of those eighteen region pairs, when the number of interactors of individual regions was considered, RT regions mapped within RNaseH domain, namely, RT-EP9, RT-NE9, and RT-EP15, were found to have strong correlation coefficients with six, six, and three IN regions, respectively, consistent with the above results. Likewise, the IN-EP2 region was also found to interact with five RT regions, in agreement with prior findings. Thus, the agreement between two approaches allows us to further narrow down the set of residues as the most likely interacting pairs for future experimental confirmation.

We also performed a sliding window analysis, in an attempt to further narrow down the range of interacting residues from large coevolving regions. A total of eighty-eight sliding window pairs were identified as the top coevolving sliding window pairs (i.e., those with the combined correlation coefficients of 0.5 or above), which in turn comprised nineteen and eight sliding windows from RT and IN, respectively. Eighteen out of nineteen and eight out of eight of top coevolving sliding windows were co-located with the top coevolving regions identified in [Table 2](#vew002-T2){ref-type="table"} and corresponded to fifty out of eighty-eight sliding window pairs. Of the remaining thirty-eight sliding window pairs that were not already represented in [Table 2](#vew002-T2){ref-type="table"}, only one pair included a novel segment from RT. We further examined the total number of coevolving regions linked to each sliding window (ranging from one to eight for RT, and three to eighteen in IN) and identified those in the top half by the number of coevolving regions (i.e., those with five to eight, and ten to eighteen regions in RT and IN, respectively) ([Table 2](#vew002-T2){ref-type="table"}). Thus, the results of the sliding window analysis were mostly consistent with prior findings and may offer additional insights into the strength of coevolutionary relationships among individual regions. This approach also can provide additional information for the design of future experimental validation or structural studies, for example, region pairs with a large number of coevolving partners may be expected to be more flexible than those with a small number of partners ([@vew002-B51]).

By using a randomization approach, we examined the possibility that strong correlations identified among multiple region pairs could be attributed to background noise instead of functional/structural constraints. The results showed that for randomized datasets, the maximum value of the upper confidence interval of the combined correlation coefficient does not exceed approximately 0.063, which is significantly smaller than the smallest combined correlation coefficient values of approximately 0.495 and approximately 0.298, which were derived from the empirical (non-randomized) datasets (*P* \< 0.001, per nonparametric two-sample rank tests) ([Table 2](#vew002-T2){ref-type="table"}, see also [Supplementary Table S4](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1) and [Fig. S5](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1)). This indicates that while it is possible that some of the detected correlations may be attributable to random noise, the reported values for the top 15 per cent region pairs cannot be attributed to random correlations.

While our study provides evidence about potentially interacting regions between IN and RT proteins, there are also known limitations of this approach. Because we used a stringent combined correlation coefficient threshold of 0.5, we may have missed potential interactions. [Supplementary Fig. S3](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1) shows a broader range of potentially interacting regions (those with combined correlation coefficient value cut-off at 0.4). Further, the lower correlation value may also be attributed to interference from other proteins/substances that play a role in the IN-RT protein complex. For example, the coevolutionary signal of two interacting regions may appear weaker and, hence, result in a relatively low score when those regions interact with multiple partners (e.g., [@vew002-B24]). Another challenge is not being able to recognize all the interacting proteins involved in a complex. For example, both IN and RT proteins are inhibited by Vpr protein, either together or possibly separately ([@vew002-B3]; [@vew002-B17]). Thus, interactions with Vpr could be mediating other interactions within the IN-RT complex (e.g., [@vew002-B17]). Although Vpr peptides could not be included in this pairwise-based approach, this question should be addressed in future studies. There is definitely a need to develop a suitable method to account for multiple partners.

Overall, the identification of coevolving residues is a promising approach to predict potential targets for multi-epitope- or adjuvant-based treatments. The inclusion of conserved functionally important epitopes from different genomic regions holds promise in eliciting a strong immune response (e.g., [@vew002-B19]), and our results help to narrow down the list of such functionally important candidates. Likewise, these functionally and/or structurally important regions can be used to design novel protein inhibitors that will target the IN-RT complex. These findings can further inform validation studies, for example, using site-directed mutagenesis, and/or be integrated with structural data and physicochemical amino acid properties to gain a better understanding of the mechanism of protein interactions between RT and IN proteins of HIV-1. For proteins with poorly resolved three-dimensional structures, like IN, coevolution analysis offers important clues to enable a better understanding of likely functional interactions and to identify specific segments and/or residues involved in interaction interfaces.

4. Conclusion
=============

Coevolutionary analysis can provide important predictions that can be integrated with structural data to gain a better understanding of the mechanisms of protein interaction between RT and IN, including interactions in transient protein--protein complexes such as the IN-RT complex within PIC. For example, our results identified multiple interactions occurring in parts of the NTD and CTD of IN. Likewise, in RT, many interactions appear to involve the Connection and RNaseH domains. Thus, these results highlight sets of residues likely involved in interaction interface(s) of HIV-1 RT and IN protein complex through coevolutionary signatures, although experimental validation of specific interactions is needed.

Supplementary data
==================

[Supplementary data](http://ve.oxfordjournals.org/lookup/suppl/doi:10.1093/ve/vew002/-/DC1) are available at *Virus Evolution* online.

###### Supplementary Table S1

This work was partially supported by NIH NIGMS grant GM86782‐01A1 to H.P. We would like to thank our fellow lab members Reeba Paul, Mary Halpin, Yi Wei and Kendall Furbee for their insightful comments.

**Conflict of interest**: None declared.

[^1]: ^a^A cluster of best-defined CTL, T-Helper, or Ab epitopes that are overlapping is defined as one epitope cluster

[^2]: For each pair of regions, combined correlation coefficient (with confidence intervals) is given. Only top 15 per cent of pairs that have the combined correlation coefficient at or above 0.5 threshold are listed.

[^3]: ^a^Sample size refers to the number of samples (out of 1,000) that had a significant Pearson correlation value in at least two-third of the total samples (i.e., 750 samples out of 1,000).

[^4]: ^b^IN/RT regions that are identified by analysis of phylogenetic independent sequence pairs.

[^5]: ^c^'+' designates whether the specific region has been identified as part of the top half of coevolving sliding windows by the number of coevolving regions (e.g., sliding windows in RT that coevolve with 5--8 IN regions; see Section 2 for further details).
